Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Millward

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
British Journal of Cancer|September 14, 2006
The multikinase inhibitor midostaurin (PKC412A) lacks activity in metastatic melanoma: a phase IIA clinical and biologic studyM J Millward, C House, D Bowtell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Phase I trial of cremophor EL with bolus doxorubicinM J Millward, L K Webster, D Rischin, et al.
Seminars in Oncology|August 24, 1999
Overview of docetaxel (Taxotere)/cisplatin combination in non-small cell lung cancerT Le Chevalier, J Bérille, J R Zalcberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Low-dose versus standard-dose lenograstim prophylaxis after chemotherapy: a randomized, crossover comparisonG C Toner, J D Shapiro, C R Laidlaw, et al.
Cancer Epidemiology|April 7, 2015
The aggregation of early-onset melanoma in young Western Australian familiesS V Ward, J G Dowty, R J Webster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancerM J Millward, J Zalcberg, J F Bishop, et al.
Bone Marrow Transplantation|April 1, 1999
Ifosfamide in combination with paclitaxel or doxorubicin: regimens which effectively mobilize peripheral blood progenitor cells while demonstrating anti-tumor activity in patients with metastatic breast cancerH M Prince, J Gardyn, M J Millward, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 20, 2015
A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesotheliomaA K Nowak, A M Cook, A M McDonnell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Phase I study of pharmacologically based dosing of carboplatin with filgrastim support in women with epithelial ovarian cancerM J Lind, S Ghazal-Aswad, L Gumbrell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I studyH M Prince, M J Millward, D Rischin, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
British Journal of Cancer|September 14, 2006
The multikinase inhibitor midostaurin (PKC412A) lacks activity in metastatic melanoma: a phase IIA clinical and biologic studyM J Millward, C House, D Bowtell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Phase I trial of cremophor EL with bolus doxorubicinM J Millward, L K Webster, D Rischin, et al.
Seminars in Oncology|August 24, 1999
Overview of docetaxel (Taxotere)/cisplatin combination in non-small cell lung cancerT Le Chevalier, J Bérille, J R Zalcberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Low-dose versus standard-dose lenograstim prophylaxis after chemotherapy: a randomized, crossover comparisonG C Toner, J D Shapiro, C R Laidlaw, et al.
Cancer Epidemiology|April 7, 2015
The aggregation of early-onset melanoma in young Western Australian familiesS V Ward, J G Dowty, R J Webster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancerM J Millward, J Zalcberg, J F Bishop, et al.
Bone Marrow Transplantation|April 1, 1999
Ifosfamide in combination with paclitaxel or doxorubicin: regimens which effectively mobilize peripheral blood progenitor cells while demonstrating anti-tumor activity in patients with metastatic breast cancerH M Prince, J Gardyn, M J Millward, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 20, 2015
A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesotheliomaA K Nowak, A M Cook, A M McDonnell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Phase I study of pharmacologically based dosing of carboplatin with filgrastim support in women with epithelial ovarian cancerM J Lind, S Ghazal-Aswad, L Gumbrell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I studyH M Prince, M J Millward, D Rischin, et al.
Pageof 6